Showing 13,041 - 13,060 results of 226,904 for search '(( a ((step decrease) OR (a decrease)) ) OR ( i ((largest decrease) OR (larger decrease)) ))', query time: 1.24s Refine Results
  1. 13041

    Image 4_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  2. 13042

    Image_1_Social Deficits and Cerebellar Degeneration in Purkinje Cell Scn8a Knockout Mice.JPEG by Xiaofan Yang (767342)

    Published 2022
    “…At 9 months of age, Scn8a<sup>flox/flox</sup>, L7Cre<sup>+</sup> mice exhibited decreased cerebellar size and a reduced number of cerebellar Purkinje cells more profoundly, with evidence of additional neurodegeneration in the molecular layer and deep cerebellar nuclei. …”
  3. 13043

    Data Sheet 1_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.pdf by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  4. 13044

    Image 1_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  5. 13045

    Table 1_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.docx by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  6. 13046

    Image 5_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  7. 13047

    Image 6_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  8. 13048

    Image 2_ATP/P2X7 receptor signal aggravates ischemic stroke injury by activating Th17 cells via STAT3/IL-21 pathway.tif by Wenying Liu (781302)

    Published 2025
    “…Rag2<sup>-/-</sup> mice that received P2X7-KO CD4<sup>+</sup>T cells demonstrated reduced ischemic-reperfusion injury and a decreased level of IL-17A and frequency of Th17 cells compared to Rag2<sup>-/-</sup> mice that received wild type CD4<sup>+</sup>T cells. …”
  9. 13049

    Image_4_Social Deficits and Cerebellar Degeneration in Purkinje Cell Scn8a Knockout Mice.JPEG by Xiaofan Yang (767342)

    Published 2022
    “…At 9 months of age, Scn8a<sup>flox/flox</sup>, L7Cre<sup>+</sup> mice exhibited decreased cerebellar size and a reduced number of cerebellar Purkinje cells more profoundly, with evidence of additional neurodegeneration in the molecular layer and deep cerebellar nuclei. …”
  10. 13050

    Data_Sheet_1_CagA+Helicobacter pylori, Not CagA–Helicobacter pylori, Infection Impairs Endothelial Function Through Exosomes-Mediated ROS Formation.pdf by Xiujuan Xia (11929241)

    Published 2022
    “…CagA<sup>+</sup>H. pylori, not CagA<sup>–</sup>H. pylori, infection significantly increased aortic ROS production, decreased ACh-induced aortic relaxation, and enhanced early atherosclerosis formation, which were prevented with N-acetylcysteine treatment. …”
  11. 13051
  12. 13052
  13. 13053
  14. 13054
  15. 13055
  16. 13056
  17. 13057
  18. 13058

    DataSheet_1_IL-40: A New B Cell-Associated Cytokine Up-Regulated in Rheumatoid Arthritis Decreases Following the Rituximab Therapy and Correlates With Disease Activity, Autoantibodies, and NETosis.docx by Adela Navrátilová (11589532)

    Published 2021
    “…Background<p>Interleukin 40 (IL-40) is a newly identified B cell-associated cytokine implicated in humoral immune responses and B cell homeostasis. …”
  19. 13059

    DataSheet_1_Effectiveness of regdanvimab treatment for SARS-CoV-2 delta variant, which exhibited decreased in vitro activity: a nationwide real-world multicenter cohort study.pdf by Haein Kim (4839594)

    Published 2023
    “…In the multivariable analysis, regdanvimab was significantly associated with a decreased risk for O<sub>2</sub> support (HR 0.677, 95% CI 0.561–0.816) and progression to severe disease (HR 0.489, 95% CI 0.337–0.709). …”
  20. 13060

    Adenosine decreases the amplitude of evoked AMPA EPSCs via activation of A<sub>1</sub> ARs without altering that of the evoked IPSCs recorded from layer III pyramidal neurons in the medial EC. by Shouping Wang (402959)

    Published 2013
    “…<b>F,</b> Bath application of dipyridamole (1 µM), an adenosine transporter inhibitor, significantly reduced the evoked EPSCs (n = 10, p<0.001, paired t-test) suggesting that endogenously released adenosine decreases AMPA EPSCs. <b>G,</b> Prior application of DPCPX, an A<sub>1</sub> AR blocker, blocked dipyridamole-induced depression of AMPA EPSCs (n = 5, p = 0.85 vs. baseline, paired t-test) suggesting that the inhibitory effect of dipyridamole is mediated via activation of A<sub>1</sub> ARs. …”